# Piper Sandler Companies: financial statements, quarterly PIPR · NYSE · CIK 1230245 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/pipr.md) · [Financials](/companies/pipr/financials.md) · [Filings](/companies/pipr/filings.md) · [Insiders](/companies/pipr/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pipr/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [292](/filings/0001230245-25-000038.md) | [474](/filings/0001230245-25-000038.md) | [344](/filings/0001230245-26-000013.md) | [341](/filings/0001230245-26-000013.md) | [361](/filings/0001230245-26-000013.md) | [485](/filings/0001230245-26-000013.md) | [378](/filings/0001230245-26-000022.md) | [395](/filings/0001230245-26-000032.md) | [480](/filings/0001230245-26-000013.md) | [667](/filings/0001230245-26-000013.md) | [459](/filings/0001230245-26-000022.md) | [473](/filings/0001230245-26-000032.md) | | Income tax | $m | [10.2](/filings/0001230245-25-000038.md) | [21.3](/filings/0001230245-25-000038.md) | [2.8](/filings/0001230245-25-000080.md) | [13.3](/filings/0001230245-25-000137.md) | [15.2](/filings/0001230245-25-000144.md) | [29.6](/filings/0001230245-25-000038.md) | [(7.3)](/filings/0001230245-26-000022.md) | [17.2](/filings/0001230245-26-000032.md) | [24.9](/filings/0001230245-25-000144.md) | [45.8 d](/filings/0001230245-26-000013.md) | [19.6](/filings/0001230245-26-000022.md) | [30.3](/filings/0001230245-26-000032.md) | | Net income | $m | [3.9](/filings/0001230245-25-000038.md) | [52.0](/filings/0001230245-25-000038.md) | [42.5](/filings/0001230245-26-000013.md) | [34.8](/filings/0001230245-26-000013.md) | [34.8](/filings/0001230245-26-000013.md) | [69.1](/filings/0001230245-26-000013.md) | [64.9](/filings/0001230245-26-000022.md) | [42.2](/filings/0001230245-26-000032.md) | [60.3](/filings/0001230245-26-000013.md) | [114](/filings/0001230245-26-000013.md) | [65.2](/filings/0001230245-26-000022.md) | [67.8](/filings/0001230245-26-000032.md) | | Diluted EPS | $ per share | [0.22](/filings/0001230245-25-000038.md) | [3.00](/filings/0001230245-25-000038.md) | [2.43](/filings/0001230245-26-000013.md) | [1.97](/filings/0001230245-26-000013.md) | [1.96](/filings/0001230245-26-000013.md) | [3.86](/filings/0001230245-26-000013.md) | [0.91](/filings/0001230245-26-000022.md) | [0.59](/filings/0001230245-26-000032.md) | [3.38](/filings/0001230245-26-000013.md) | [6.40](/filings/0001230245-26-000013.md) | [0.92](/filings/0001230245-26-000022.md) | [0.95](/filings/0001230245-26-000032.md) | | Basic EPS | $ per share | [0.26](/filings/0001230245-25-000038.md) | [3.44](/filings/0001230245-25-000038.md) | [2.74](/filings/0001230245-26-000013.md) | [2.19](/filings/0001230245-26-000013.md) | [2.19](/filings/0001230245-26-000013.md) | [4.30](/filings/0001230245-26-000013.md) | [0.99](/filings/0001230245-26-000022.md) | [0.63](/filings/0001230245-26-000032.md) | [3.61](/filings/0001230245-26-000013.md) | [6.77](/filings/0001230245-26-000013.md) | [0.96](/filings/0001230245-26-000022.md) | [1.00](/filings/0001230245-26-000032.md) | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Total assets | $m | [1,965](/filings/0001230245-23-000154.md) | [2,141](/filings/0001230245-25-000038.md) | [1,822](/filings/0001230245-24-000083.md) | [1,920](/filings/0001230245-24-000132.md) | [2,032](/filings/0001230245-24-000179.md) | [2,256](/filings/0001230245-26-000013.md) | [1,821](/filings/0001230245-25-000080.md) | [1,959](/filings/0001230245-25-000137.md) | [2,220](/filings/0001230245-25-000144.md) | [2,593](/filings/0001230245-26-000032.md) | [2,130](/filings/0001230245-26-000022.md) | [2,327](/filings/0001230245-26-000032.md) | | Total liabilities | $m | [747](/filings/0001230245-23-000154.md) | [842](/filings/0001230245-25-000038.md) | [497](/filings/0001230245-24-000083.md) | [579](/filings/0001230245-24-000132.md) | [670](/filings/0001230245-24-000179.md) | [840](/filings/0001230245-26-000013.md) | [442](/filings/0001230245-25-000080.md) | [560](/filings/0001230245-25-000137.md) | [757](/filings/0001230245-25-000144.md) | [1,010](/filings/0001230245-26-000032.md) | [572](/filings/0001230245-26-000022.md) | [759](/filings/0001230245-26-000032.md) | | Long-term debt | $m | [125](/filings/0001230245-23-000154.md) | [0.0](/filings/0001230245-24-000038.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | [30.0](/filings/0001230245-25-000038.md) | [0.0](/filings/0001230245-24-000083.md) | [0.0](/filings/0001230245-24-000132.md) | [20.0](/filings/0001230245-24-000179.md) | [10.0](/filings/0001230245-26-000013.md) | [15.0](/filings/0001230245-25-000080.md) | [15.0](/filings/0001230245-25-000137.md) | [15.0](/filings/0001230245-25-000144.md) | [15.0](/filings/0001230245-26-000032.md) | [15.0](/filings/0001230245-26-000022.md) | [15.0](/filings/0001230245-26-000032.md) | | Shareholders' equity | $m | [1,034](/filings/0001230245-23-000154.md) | [1,085](/filings/0001230245-25-000038.md) | [1,101](/filings/0001230245-24-000083.md) | [1,126](/filings/0001230245-24-000132.md) | [1,167](/filings/0001230245-24-000179.md) | [1,228](/filings/0001230245-26-000013.md) | [1,213](/filings/0001230245-25-000080.md) | [1,230](/filings/0001230245-25-000137.md) | [1,283](/filings/0001230245-25-000144.md) | [1,371](/filings/0001230245-26-000032.md) | [1,342](/filings/0001230245-26-000022.md) | [1,373](/filings/0001230245-26-000032.md) | - Cash and equivalents: not reported - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [27.3 d](/filings/0001230245-24-000179.md) | [423 d](/filings/0001230245-26-000013.md) | [(197)](/filings/0001230245-25-000080.md) | [266 d](/filings/0001230245-25-000137.md) | [80.1 d](/filings/0001230245-25-000144.md) | [164 d](/filings/0001230245-26-000013.md) | [(207)](/filings/0001230245-26-000022.md) | [32.1 d](/filings/0001230245-26-000032.md) | [31.9 d](/filings/0001230245-25-000144.md) | [730 d](/filings/0001230245-26-000013.md) | [(292)](/filings/0001230245-26-000022.md) | [36.3 d](/filings/0001230245-26-000032.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Dividends paid | $m | [10.1 d](/filings/0001230245-24-000179.md) | [10.2 d](/filings/0001230245-26-000013.md) | [35.7](/filings/0001230245-25-000080.md) | [14.8 d](/filings/0001230245-25-000137.md) | [10.7 d](/filings/0001230245-25-000144.md) | [12.6 d](/filings/0001230245-26-000013.md) | [70.3](/filings/0001230245-26-000022.md) | [17.1 d](/filings/0001230245-26-000032.md) | [11.9 d](/filings/0001230245-25-000144.md) | [14.9 d](/filings/0001230245-26-000013.md) | [101](/filings/0001230245-26-000022.md) | [13.8 d](/filings/0001230245-26-000032.md) | | Share repurchases | $m | [3.9 d](/filings/0001230245-24-000179.md) | [3.1 d](/filings/0001230245-26-000013.md) | [52.1](/filings/0001230245-25-000080.md) | [5.5 d](/filings/0001230245-25-000137.md) | [2.4 d](/filings/0001230245-25-000144.md) | [6.5 d](/filings/0001230245-26-000013.md) | [80.6](/filings/0001230245-26-000022.md) | [20.9 d](/filings/0001230245-26-000032.md) | [3.7 d](/filings/0001230245-25-000144.md) | [19.8 d](/filings/0001230245-26-000013.md) | [69.9](/filings/0001230245-26-000022.md) | [31.0 d](/filings/0001230245-26-000032.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: not reported - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [17.3](/filings/0001230245-25-000038.md) | [17.4](/filings/0001230245-25-000038.md) | [17.5](/filings/0001230245-26-000013.md) | [17.6](/filings/0001230245-26-000013.md) | [17.8](/filings/0001230245-26-000013.md) | [17.9](/filings/0001230245-26-000013.md) | [71.2](/filings/0001230245-26-000022.md) | [70.9](/filings/0001230245-26-000032.md) | [17.8](/filings/0001230245-26-000013.md) | [17.8](/filings/0001230245-26-000013.md) | [71.2](/filings/0001230245-26-000022.md) | [71.2](/filings/0001230245-26-000032.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 70,670,291 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001230245-26-000032.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.